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We found only one individual diagnosed with atypical
cellular neurofibroma from the pathology files of the
Department of Pathology, Kaohsiung Medical Univer-
sity Hospital, the medical center of south Taiwan,
between 1988 and 2005. We went through the litera-
ture on the subject and found that this was an unusual
entity. We reviewed all the section slides and had the
full immunohistochemical panel needed for differen-
tial diagnosis of the disease. The section slides were
reviewed by two pathologists. The clinical informa-
tion was obtained from the medical records and the
surgeon. Here, we report an additional case of atypical
cellular neurofibroma originating from the first and
third lumbar spines (L1 and L3) in the same patient. We
discuss the reason for discordance between the frozen
and permanent section slides. The magnetic resonance
imaging (MRI), CD34 positive cells, and areas of high
p53 staining, which were up to 73% in our case, are
described. The literature on this subject is reviewed.
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A case of two sporadic cellular neurofibromas with atypia and one widespread hyalinization
neurofibroma of the lumbar spine in a 51-year-old man without evidence of neurofibromatosis-1
is reported. Cellular neurofibroma with atypia is an unusual variant. The definite criteria for low-
grade and high-grade malignant peripheral nerve sheath tumors as well as cellular neurofibroma
are not well defined in the literature. The clinical significance of atypical cellular neurofibroma
has rarely been systematically studied. To our knowledge, the concomitance of cellular architec-
ture and cytologic atypia is rarely documented, and this is a rare report of atypical cellular neu-
rofibroma. The recognition of this entity is of great importance to both pathologists and clinicians
because atypical cellular neurofibroma is clever at masquerading both histologically and cytolog-
ically as a sarcoma; therefore, a precise diagnosis of this variant is essential because of the differ-
ences in treatment and clinical behavior between benignancy and malignancy. We also examined
the immunohistochemical characteristics of CD34 positive cells and focal high expression of 
p53 up to 73% encountered in our case. To our knowledge, seldom have series or case reports 
elucidated this phenomenon.
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CASE PRESENTATION
A 51-year-old Taiwanese man had complained of
numbness in bilateral thighs and legs for several
months. He was admitted to our neurosurgical ward
on September 3, 2003. No pelvic pain, constipation,
urinary urgency, weight loss, hematuria, or dysuria
was reported. Apart from having a medical history of
hypertension for years, and a past history of soft tis-
sue mass around the first sacral foramen that was
excised in 1998, there was no other significant past
medical history. His physical examination and labora-
tory data were unremarkable. MRI showed two rela-
tively well-defined lesions involving L1 and L3. They
were both lobulated intradural extramedullary nod-
ules roughly 18 mm and 10 mm in greatest diameter.
MRI with contrast enhancement showed nodules
with homogeneous enhancement. A few tiny low sig-
nal dots within the homogeneously enhanced lesion
were noted that manifested no contrast enhancement;
the largest was approximately 2.5 mm (Figure 1). The
cornus medullaris was compressed. In addition, the
previous surgical site of L5–S1 disc displayed a low
T2 signal and enhancement. There were spurs at
lumbar spines, though their alignment was unre-
markable. The abnormal signal in the thecal sac was
not identified, though there was no abnormal signal
intensity over the bony vertebra. The paraspinal soft
tissue remained unremarkable. Radiographic findings
of both lesions were interpreted as arteriove-
nous malformation. The differential diagnosis included
meningioma, ependymoma, and metastatic disease.
Surgery was subsequently performed. At surgery, L1
had a round intradural and extramedullary nodule,
and L3 had a diffuse infiltrating lesion within the ter-
minal filament. The tumor was entirely removed. The
patient was regularly followed up in our clinics and
had an unremarkable postoperative course. So far,
there has been no evidence of recurrence.
The excised surgical specimen for frozen section
consisted of 10 tiny grayish-white tissue fragments,
measuring up to 1.2˜0.6˜0.5cm in size. The excised
surgical specimen submitted later comprised seven
solid grayish-white tissue fragments in two separate
bags measuring up to 1˜1˜0.4cm in size. The cut sur-
face was white-tan. No hemorrhage, necrosis, or cystic
changes were identified grossly. The frozen section
slides confirmed that the histology of the neoplasm
was a solid hypercellular tumor. It was formed either
by short interlacing fascicles or by whorled patterns
of spindle cells. It was characterized by foci of a 
palisading-like pattern, hemorrhage, and inflamma-
tion. The compact and highly cellular spindle cells
showed somewhat hyperchromatic nuclei with eosino-
philic cytoplasm and indistinct cell borders. There was
moderate nuclear atypia with occasional cells having
large bizarre nuclei. No active mitoses and necrosis
were identified (Figure 1). The tentative frozen section
diagnosis was meningioma. The differential diagnosis
was schwannoma.
The permanent section slides showed a similar
histology as the frozen section slides. Nevertheless,
some cells had larger and more smudged nuclei with-
out distinct nucleoli (Figure 1). In some areas, the
spindle cells had long wavy nuclei with tapered ends.
Some had oval, round, short spindle nuclei, or had
nuclear pseudo-inclusions. Foci of small, thin, and slit-
like vessels and vacuolated cells were seen. Immu-
nohistochemical features of the spindle cells were
strongly positive for S-100 (Figure 2A) and vimentin. In
focal areas, an extreme minority of cells had strong
positive staining for glial fibrillary acidic protein
(GFAP), synaptophysin, and neurofilament protein
(NFP). Some collagen fibers were seen in Masson’s
trichrome stain. Cytokeratin, CD117 (c-Kit), epithelial
membrane antigen, and smooth muscle actin were all
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Figure 1. Tumor with nuclear atypia. Note the presence of enlarged
cells with bizarre nuclei, smudged chromatin, and abundance of
cytoplasm (hematoxylin and eosin [H&E], original magnification
400˜). Inset A: highly cellular spindle cells of the atypical cellular
neurofibroma in fascicular pattern of growth (H&E, original mag-
nification 40˜). Insert B: sagittal T1-weighted image with contrast
enhancement shows two well-defined tumors. However, one tiny
but obvious low-signal intensity area is seen within the L1 tumor.
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negative. CD34 was diffusely negative except for the
areas of vacuolated cells (Figure 2B). Proliferation index
(Ki-67) and positive p53 staining were scored by count-
ing the percentage of positive cells in one high power
field (HPF) in the section slide. Then, the positive rate
was the average of the positive percentage of all HPFs
in the whole section slide. Ki-67 was 0% (Figure 2C).
The positive rate of p53 staining varied, ranging from
less than 1% to as high as 73% (Figure 2D); however,
the average percentage of p53 in the whole section
slide was approximately 2%.
The section slides from the previous surgery in
1998 were reviewed. They showed extensive hyalini-
zation with a low density of spindle cells and bland
nuclei (Figure 3A). Some cells had wavy nuclei. There
was no hemorrhage, necrosis, or active mitoses (Figure
3B). Immunohistochemical study showed collagen
component seen on Masson’s trichrome stain (Figure
3C). S-100 was diffusely positive (Figure 3D).
DISCUSSION
Neurofibroma can occur either as sporadic solitary
nodules or as multiple lesions in individuals with
neurofibromatosis-1 (NF1) [1]. It is composed of
neoplastic Schwann cells, fibroblasts, perineurium-
like cells, and cells intermediate between fibroblasts
and perineurial-like cells embedded in a collagen
matrix [2,3]. The diagnosis of conventional neuro-
fibroma is easy due to the above characteristic patho-
logic features. Atypical neurofibroma is neurofibroma
with cytologic atypia, and cellular neurofibroma des-
cribed by others is one with increased cellularity [3].
In our case, the whole tumor was exclusively hypercel-
lular with a high ratio of cytologic atypia. The histologic
pattern was quite different from conventional neu-
rofibroma and those described in the literature [3].
These histologic features occasionally make it diffi-
cult to distinguish atypical cellular neurofibroma
from low-grade malignant peripheral nerve sheath
tumor (MPNST), cellular schwannoma, and other
spindle cell tumors [4]. Cellular schwannoma has the
characteristics of high cellularity and lack of Antoni B
pattern with occasional ancient changes that comprise
nuclear pleomorphism, hyperchromasia, and micro-
cystic or macrocystic change [5,6]. In our patient, 
the histopathologic features were suggestive of cel-
lular schwannoma. Both neurofibroma and cellular
schwannoma are positive for S-100 [2,7]. While the
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Figure 2. Immunohistochemical features. (A) S-100 diffusely positive. (B) Focal strong CD34 immunopositivity. (C) Ki-67 diffusely
negative. (D) Focal extremely high p53 expression. (All immunohistochemical stain and original magnification 400˜.)
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histopathologic features of cellular schwannomas
have been described, atypical cellular neurofibromas
have rarely been studied. To our knowledge, there is
no report that details how atypical cellular neurofi-
bromas may be differentiated from cellular schwan-
noma. We even encountered a conceptual challenge
in one paper that some nerve sheath tumors may
contain histologic components of both neurofibro-
mas and schwannomas, suggesting a closer relation-
ship between the two than previously recognized [8].
In our case, a tiny focal area of entrapped neurons and
a few cells that were strongly positive for GFAP, NFP,
and synaptophysin were seen. The collagen in the
matrix is not easily appreciated histopathologically,
but could be clearly outlined on Masson’s trichrome
stain. Only one veterinary paper appears to have such
a full panel of immunohistochemistry with detailed
immunohistochemical-staining pattern fully studied
like ours [9]. Based on the histopathologic features and
those described in the literature, the histologic constitu-
ents of our case were not composed of pure Schwann
cells—small wonder then that we had the immuno-
histochemical pattern of GFAP, NFP, synaptophysin,
and Masson’s trichrome stains. Furthermore, no hya-
line thick-walled vessel was seen on our section
slides. Hence, the presence of the above findings rules
out cellular schwannoma. More difficult is the differ-
ential diagnosis between atypical cellular neurofibroma
and low-grade MPNST [1,4]. Malignant transformation
from neurofibroma to MPNST has been fully studied,
especially in patients suffering from NF1 (von Reckling-
hausen’s disease) [3,4,10,11]. Although expanding
studies on MPNST have emerged, there is no universal
consensus on how MPNST should be diagnosed due to
its morphologic diversity [2,4,11]. This is true especially 
for low-grade MPNST [2]. The lack of standardized
diagnostic criteria makes the diagnosis of low-grade
MPNST more difficult [2]. Some studies have found the
presence of any mitoses significant, while others place
the emphasis on hypercellularity, diffuse nuclear
enlargement at least three times the size of conven-
tional neurofibroma nuclei, and diffuse hyperchroma-
sia [2]. Therefore, several ancillary studies comparing
the expression of immunohistochemical variables
between benign peripheral nerve sheath tumors and
MPNST have been published [12,13]. Among these
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Figure 3. (A, B) Photomicrographs of specimen show elongated or wavy nuclei with extensive hyalinization (hematoxylin and eosin,
original magnification 40˜ in A and 400˜ in B). (C) Immunohistochemical staining shows abundant collagen in the background (orig-
inal magnification 400˜). (D) Immunohistochemical staining shows diffusely positive staining of S-100 protein in the tumor cells
(original magnification 400˜).
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immunohistochemical variables, p53 and Ki-67 were
the most widely studied and potential markers in
detecting neurofibroma with malignant transforma-
tion [12–15], which captured our interest. While the
significance has been confirmed in a majority of stud-
ies, there are variable methods of estimating the p53
and Ki-67 markers [12–16]. The range between benign
and malignant components of MPNST also varied
greatly [12–16]. Studies have shown that p53 plays 
an important role in malignant transformation [14,16].
In our case, p53 was strongly positive mostly in the
atypical cells as previously reported [14]. Also, the
range of p53 staining varied greatly from less than
1% to 73%. If the biopsy specimen is small and acci-
dental in this high p53 staining area, malignancy may
be misdiagnosed. When we counted all the p53 posi-
tive cells in every HPF on our slides, we found that
the average p53 positivity was about 2%. In our case,
Ki-67 was 0%. We believe that no report has previously
described this odd staining pattern. Consequently,
we found that the sample size of the surgical specimen,
the method of counting the positive cells, and an appro-
priate immunohistochemistry panel are all important
in the differential diagnosis. It is dangerous to make 
a diagnosis of malignancy solely on one immunohisto-
chemical marker. At least two markers are needed.
Focal vacuolated cells and CD34 intense immuno-
reactivity in our case drew our attention because these
cells in neurofibroma are seldom referred to in text-
books. We found a few reports elucidating the charac-
teristics of these cells [17–19]. A few unusual histologic
features encountered in neurofibroma include rosette
formation, focal rhabdomyomatous feature, vacuol-
ated cells, and myxoid change. We found that the
previous surgical specimens in this patient had the
unusual feature of extensive hyalinization. The vac-
uolated cells in the surgical specimens this time had
another one of the several unusual histologic features
of neurofibroma and were confirmed to be a highly
characteristic feature of endoneurial neurofibroma [17].
To our knowledge, no such feature in atypical cellu-
lar neurofibroma has been reported by other authors
in the literature. This study is the first to introduce
this component of atypical cellular neurofibroma.
We found well-circumscribed and homogeneous
lesions with strong enhancement on MRI. Tiny low-
signal cystic-like areas were also seen. Our radiologist
thought that cystic change or vessels might be possible
as an atypical feature of neurofibroma. The image was
in accordance with a previous report [20]. We assume
that MRI is not a reliable tool for distinguishing benign
and malignant peripheral nerve sheath tumors.
Based on the histopathologic features of heteroge-
neous groups of cells, clinical presentation, and the
appropriate immunohistochemistry panel, we made
the diagnosis of atypical neurofibroma [4,6,7,9,11]. In
conclusion, a thorough study of the histopathologic
features, along with clinical presentation, and the uti-
lization of ancillary studies, particularly an appropri-
ate panel of immunohistochemistry, is helpful in the
diagnosis of atypical cellular neurofibroma [11].
REFERENCES
1. Sungur N, Uysal A, Koçer U, et al. Early malignant
change in a solitary neurofibroma not associated with
neurofibromatosis: a case report. Eur J Plast Surg 2005;
28:105–8.
2. Woodruff JM. Pathology of tumors of the peripheral
nerve sheath in type 1 neurofibromatosis. Am J Med
Genet 1999;89:23–30.
3. Lin BT, Weiss LM, Medeiros LJ. Neurofibroma and cel-
lular neurofibroma with atypia: a report of 14 tumors.
Am J Surg Pathol 1997;21:1443–9.
4. Yamaguchi U, Hasegawa T, Hirose T, et al. Low-grade
malignant peripheral nerve sheath tumor: varied cyto-
logical and histological patterns. J Clin Pathol 2003;56:
826–30.
5. Henke AC, Salomao DR, Hughes JH. Cellular schwan-
noma mimics a sarcoma: an example of a potential pit-
fall in aspiration cytodiagnosis. Diagn Cytopathol 1999;
20:312–6.
6. Laforga JB. Cellular schwannoma: report of a case
diagnosed intraoperatively with the aid of cytologic
imprints. Diagn Cytopathol 2003;29:95–100.
7. Koizumi Y, Utsunomiya T, Yamamoto H. Cellular
schwannoma in the oral mucosa. Acta Otolaryngol
2002;122:458–62.
8. Feany MB, Anthony DC, Fletcher CD. Nerve sheath
tumours with hybrid features of neurofibroma and
schwannoma: a conceptual challenge. Histopathology
1998;32:405–10.
9. Chijiwa K, Uchida K, Tateyama S. Immunohisto-
chemical evaluation of canine peripheral nerve sheath
tumors and other soft tissue sarcomas. Vet Pathol 2004;
41:307–18.
10. Molenaar WM, Dijkhuizen T, van Echten J, et al.
Cytogenetic support for early malignant change in a
diffuse neurofibroma not associated with neurofibro-
matosis. Cancer Genet Cytogenet 1997;97:70–2.
11. Molina CP, Putegnat BB, Logroño R. Fine-needle aspira-
tion cytology and core biopsy of malignant peripheral
Cellular neurofibroma with atypia mimics sarcoma
Kaohsiung J Med Sci October 2006 • Vol 22 • No 10 513
nerve sheath tumor of the uterus: a case report. Diagn
Cytopathol 2001;24:347–51.
12. Kindblom LG, Ahlden M, Meis-Kindblom JM, et al.
Immunohistochemical and molecular analysis of p53,
MDM2, proliferating cell nuclear antigen and Ki67 in
benign and malignant peripheral nerve sheath tumours.
Virchows Arch 1995;427:19–26.
13. Wilkinson JS, Reid H, Armstrong GR. Malignant trans-
formation of a recurrent vestibular schwannoma. J Clin
Pathol 2004;57:109–10.
14. Mikami Y, Hidaka T, Akisada T, et al. Malignant
peripheral nerve sheath tumor arising in benign ancient
schwannoma: a case report with an immunohisto-
chemical study. Pathol Int 2000;50:156–61.
15. Liapis H, Marley EF, Lin Y, et al. p53 and Ki-67 prolifer-
ating cell nuclear antigen in benign and malignant
peripheral nerve sheath tumors in children. Pediatr Dev
Pathol 1999;2:377–84.
16. Watanabe T, Oda Y, Tamiya S, et al. Malignant periph-
eral nerve sheath tumour arising within neurofibroma.
An immunohistochemical analysis in the comparison
between benign and malignant components. J Clin Pathol
2001;54:631–6.
17. Hattori H. Vacuolated cells in neurofibroma. An
immunohistochemical study. J Cutan Pathol 2005;32:
158–61.
18. Khalifa MA, Montgomery EA, Ismiil N, et al. What are
the CD34+ cells in benign peripheral nerve sheath
tumors? Double immunostaining study of CD34 and
S-100 protein. Am J Clin Pathol 2000;114:123–6.
19. Hirose T, Tani T, Shimada T, et al. Immunohisto-
chemical demonstration of EMA/Glt1-positive peri-
neural cells and CD34-positive fibroblastic cells in
peripheral nerve sheath tumors. Mod Pathol 2003;16:
293–8.
20. Mautner VF, Friedrich RE, von Deimling A, et al.
Malignant peripheral nerve sheath tumours in neurofi-
bromatosis type 1: MRI supports the diagnosis of
malignant plexiform neurofibroma. Neuroradiology 2003;
45:618–25.
514 Kaohsiung J Med Sci October 2006 • Vol 22 • No 10
 !"VQ==NO==NO=
 !"VR==P==OQ=
 !"#$%&'
 !"#$%&'(
 UNO !"#QUO
 !"#$%&'()*+, -
 !"#$%&'()*+
 !"#$%
 
NIP
= = 
Q
= = 
R
= = 
NIOIP
 !"!#$ %= =
N
 = =
Q
 != =
R
 !"
O
 !"#$%= = 
P
 !"!= = !"#$
 !"#$%&'()'*+,-./01234=RN= !"#$%&'
 !"#$%&'()*+$,-. /012345678 9:;'(
 !"#$%&' (&' )*+,-./"01+2345617
 !"#$%&'()* +,-./0#$'(1234564789:;
 !"#$%&'()*+,-./*0"12345%6789:;<%-
 !"#$%&'()*+,-.*+/(0123456789:;<=>?
 !"#$%&'()*+,-./012./3,456789:;<=>?
 !"#$%&'()*+,-./01234567%892:;<+,-
 !"#$%&'#$()*+,-./0123456789:;3<
 !"#$%&'()*+,-./-01#23.014&56 78#9:
 !"=`aPQ= !"#$%&=éRP==TPB= !"#$%&
 !"#$%&'()*+,-$./01
 `aPQ !"#$%&'()#$'()#$'*JNéRP 
E !=OMMSXOOWRMUNQF
